Clinical Trial Update: Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update of a vaccine therapy in patients with Hodgkin lymphoma after first-line therapy; the study was terminated and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-02-28